NE 100.
D000818:Animals; D000840:Anisoles / Q000494:pharmacology*; D014150:Antipsychotic Agents / Q000494:pharmacology*; D001526:Behavioral Symptoms / Q000188:drug therapy; D017321:Clinical Trials, Phase I as Topic; D015507:Drugs, Investigational / Q000494:pharmacology*; D006801:Humans; D011437:Propylamines / Q000494:pharmacology*
D000840:Anisoles; D014150:Antipsychotic Agents; D015507:Drugs, Investigational; D011437:Propylamines; C083832:N,N-dipropyl-2-(4-methoxy-3-(2-phenylethoxy)phenyl)ethylamine monohydrochloride